generic glp-1 medications Diabetes patients now have access to first medication: ‘More accessible and affordable’ Consumer group presses U.S. to
Description
10.1038/ijo.2013.149 76 le RouxC

10.1093/jscr/rjad205 72

[DOI] [PubMed] [Google Scholar] 188.Tinsley G.M., Heymsfield S.B

currently setmelanotide is the only FDA-approved medication in this age group, specifically approved for BardetBiedl syndrome or monogenic obesity due to specific genetic mutations [16,17]
Combination therapies: Manufacturing companies and research organizations are heavily investing in research activities for developing combination therapies such as insulin with GLP-1 RA which can help in improving glycemic control, weight control and also for potential cardiovascular and kidney benefits further providing an individualized approach for patient treatment

Drug access, food and nutrition insecurity, and nutrition and culinary knowledge influence equitable obesity management with GLP-1s
